Your browser doesn't support javascript.
loading
Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.
López-Valero, Israel; Saiz-Ladera, Cristina; Torres, Sofía; Hernández-Tiedra, Sonia; García-Taboada, Elena; Rodríguez-Fornés, Fátima; Barba, Marina; Dávila, David; Salvador-Tormo, Nélida; Guzmán, Manuel; Sepúlveda, Juan M; Sánchez-Gómez, Pilar; Lorente, Mar; Velasco, Guillermo.
Afiliação
  • López-Valero I; Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, Madrid, Spain; Instituto de Investigaciones Sanitarias San Carlos (IdISSC), 28040 Madrid, Spain; Instituto Universitario de Investigación Neuroquímica, Complutense University, 28040 Madrid, Spain.
  • Saiz-Ladera C; Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, Madrid, Spain; Instituto de Investigaciones Sanitarias San Carlos (IdISSC), 28040 Madrid, Spain; Instituto Universitario de Investigación Neuroquímica, Complutense University, 28040 Madrid, Spain.
  • Torres S; Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, Madrid, Spain.
  • Hernández-Tiedra S; Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, Madrid, Spain; Instituto de Investigaciones Sanitarias San Carlos (IdISSC), 28040 Madrid, Spain.
  • García-Taboada E; Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, Madrid, Spain; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas, Spain.
  • Rodríguez-Fornés F; Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, Madrid, Spain.
  • Barba M; Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, Madrid, Spain.
  • Dávila D; Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, Madrid, Spain; Instituto de Investigaciones Sanitarias San Carlos (IdISSC), 28040 Madrid, Spain.
  • Salvador-Tormo N; Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, Madrid, Spain; Instituto de Investigaciones Sanitarias San Carlos (IdISSC), 28040 Madrid, Spain.
  • Guzmán M; Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, Madrid, Spain; Instituto Universitario de Investigación Neuroquímica, Complutense University, 28040 Madrid, Spain; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas, Spain.
  • Sepúlveda JM; Neuro-oncology Unit, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Sánchez-Gómez P; Neuro-oncology Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
  • Lorente M; Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, Madrid, Spain; Instituto de Investigaciones Sanitarias San Carlos (IdISSC), 28040 Madrid, Spain; Instituto Universitario de Investigación Neuroquímica, Complutense University, 28040 Madrid, Spain.
  • Velasco G; Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, Madrid, Spain; Instituto de Investigaciones Sanitarias San Carlos (IdISSC), 28040 Madrid, Spain; Instituto Universitario de Investigación Neuroquímica, Complutense University, 28040 Madrid, Spain. Electron
Biochem Pharmacol ; 157: 266-274, 2018 11.
Article em En | MEDLINE | ID: mdl-30195736
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dronabinol / Células-Tronco Neoplásicas / Neoplasias Encefálicas / Canabidiol / Protocolos de Quimioterapia Combinada Antineoplásica / Glioblastoma / Temozolomida Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dronabinol / Células-Tronco Neoplásicas / Neoplasias Encefálicas / Canabidiol / Protocolos de Quimioterapia Combinada Antineoplásica / Glioblastoma / Temozolomida Idioma: En Ano de publicação: 2018 Tipo de documento: Article